TruthArchive.ai - Related Video Feed

The issue of nutritional labeling is not new. In 2010, the National Academy of Medicine recommended clearer labels, yet childhood obesity has tripled since the 1970s, and the FDA has not acted swiftly. Other countries manage to implement warning labels, so why can't the U.S.? The response involves complex judicial and legislative challenges, including corporate rights. Despite the urgency of the health crisis, there is frustration over the lack of action against the food and beverage industry, which heavily lobbies against change. While acknowledging the industry's influence, there is a call for a thoughtful approach to reform that considers all stakeholders, including farmers. The time for action has been long overdue, and the health of both children and adults is at stake.

Good news: Legislative efforts to ban dangerous COVID-19 mRNA injections are underway in multiple US states. Washington, Montana, Idaho, Iowa, Tennessee, South Carolina, Florida, and Texas are considering bans at various government levels. A peer-reviewed study with over 81,000 signatories calls for immediate market withdrawal due to negative efficacy, DNA contamination, and excess mortality. This momentum, fueled by persistent public demand, may force federal action. The goal is to ban all mRNA gene therapy injections, not just those for COVID-19. The evidence is clear and compelling, highlighting the harm caused by this technology, and the hope is that state-level initiatives will lead to federal bans, ultimately removing these dangerous products from the market. Follow Nick Höltscher (@NickHolscher) and the McCullough Foundation (@McCulloughFund) for updates.

There are 1,800 big pharma lobbyists in Washington, influencing policies significantly. This raises concerns about their impact on public health and safety. To combat this, one solution is to prohibit government officials from becoming lobbyists after their term. Currently, there are regulations that limit this, but they often allow for loopholes, enabling former officials to work for companies they once regulated. This creates conflicts of interest, as seen with the Sackler family and the FDA. While addressing these issues is crucial, it often gets sidelined by other pressing matters.

The speaker questions why the FDA isn't investigating excess deaths. They highlight a significant increase in American deaths in 2023, particularly among younger age groups. The speaker notes a drop in life expectancy and points out that white-collar workers were disproportionately affected. They suggest a major workplace event in Q3 of 2021 as a potential cause for the spike in deaths.

This is a systemic issue that needs addressing. I've expressed concern about a future where the FDA is remembered for allowing society to gain weight annually, only to respond with an expensive drug costing $20,000 a year. That would leave a troubling legacy. I hope we can find a better solution.

Some states are not taking necessary actions to control the outbreak because they are led by Republicans who dislike being told what to do. It is important to address this resistance and find a solution.

The speaker claims Americans didn't die under President Trump and criticizes the Biden administration's infant formula failures, where mothers were blocked from ordering safe formulas from overseas. The speaker also criticizes the FDA's ban on raw milk, which is sold in many countries, and accuses the FDA of declaring war on anything natural while allowing chemicals in American foods, contributing to obesity and sickness. The FDA's failure to approve safer nicotine products has led to a dangerous illegal market of Chinese vapes. China has been murdering Americans for years with fentanyl. The FDA has also failed to regulate hemp-derived products and needs to crack down on counterfeit drugs from China. President Trump's executive order ending the de minimis package exemption for low-value imports will help the FDA restrict illicit products from China. The speaker believes Americans don't trust the FDA and that the COVID vaccine FDA approval should be revoked and removed from the childhood vaccine schedule, as children had the lowest hospitalization rates and deaths during COVID.

I want to discuss Red 3 and Red 40. The FDA considers food coloring like Red 40 safe for children, but it hasn't been evaluated in over a decade. Regarding Red 3, which is known to cause cancer in cosmetics, a petition is pending to revoke its authorization for food use. The FDA is expected to act on this soon. Red 3 is recognized as carcinogenic in laboratory animals, but the scientific consensus is that this risk does not apply to humans. However, the Delaney clause prohibits any chemical shown to be carcinogenic in animals or humans from being authorized by the FDA. This presents a challenge, as there is evidence suggesting it may not be harmful to humans despite its classification.

The FDA has made little progress in addressing the obesity and type 2 diabetes epidemics affecting millions of Americans. Despite a 2010 recommendation for front-of-package nutrition labels, the FDA has repeatedly missed deadlines for implementation. Other countries, like Chile and Peru, have successfully reduced unhealthy food consumption through similar labeling laws. To combat these health issues, strong warning labels on unhealthy foods and a ban on junk food advertising targeted at children are essential. Research suggests that banning such ads could significantly reduce childhood obesity rates. Additionally, there is a need to lower the high prices of diabetes and weight loss medications. Legislation has been introduced to require warning labels and ban junk food ads aimed at children, highlighting the urgency of addressing these public health concerns.

Black people are critical to saving America from Joe Biden due to his past actions and statements. Some black men are supporting Donald Trump and the conservative movement, feeling they have been voting against their own interests for years. Others question how anyone can still support the current administration given rising costs and global chaos.

Drug companies are teaming up with big agencies and tech platforms to censor social communication, limiting our ability to share information. Manufacturers and the FDA manipulate science to meet regulatory requirements, leading to harmful products. The regulatory system is a facade, and the public is paying for products that harm instead of help. This manipulation must be stopped. Translation: Drug companies are working with big agencies and tech platforms to censor communication, preventing us from sharing information. Manufacturers and the FDA manipulate science to meet regulations, resulting in harmful products. The regulatory system is a facade, and the public is paying for products that harm instead of help. This manipulation must be stopped.

A recent report describes a cyberattack and censorship surrounding a peer‑reviewed study that examines cancer diagnoses in relation to COVID vaccination. The study appeared in Oncotarget on January 3 and was authored by cancer researchers from Tufts University and Brown University. It analyzed 69 previously published case reports from around the world, identifying 333 instances where cancer was newly diagnosed or rapidly worsened within a few weeks after vaccination. The Daily Mail reported that the journal hosting the study was hit by a cyberattack that took the site offline, and that the attack helped propel the paper into broader public attention. The piece notes that the cyberattack was described to have disrupted Oncotarget’s online operations and that the FBI was informed of the incident, though the FBI reportedly would not confirm or deny whether it is investigating the attack. Among the paper’s authors is Dr. Wafiq Eldiri, who faced ongoing public backlash and personal attacks, including labels such as "scientifically illiterate," "pathetic," and racial insults, as part of a smear campaign tied to the study. Eldiri publicly described the personal attacks he has endured for pursuing the work and stated that he believes it should not be acceptable to attack a physician and biomedical researcher for presenting published literature on COVID infection, COVID vaccines, and cancer. In a striking twist, two days after the paper’s publication, Pfizer reportedly reached out to recruit Eldiri, praising his expertise in oncologic sciences and offering senior positions. Eldiri released the message publicly and rejected the offer, noting the irony of receiving a Pfizer recruiter message on January 5, 2026. Eldiri has been vocal about the need for thorough investigations into vaccine safety signals, including potential DNA integration, immune suppression, and cancer risks that could, if substantiated, prompt reconsideration or revocation of emergency use approvals. He suggested that the FDA should work toward revoking or restricting COVID mRNA vaccine approvals if there is insufficient evidence of safety and manufacturing cleanliness, and that evidence should undergo high standards of scrutiny given concerns about assays and reporting of adverse events. The discussion references other figures and voices in the debate, including Dr. Mary Talley Boden’s assertion that “now we know why the shots are still on the market,” and Dr. Robert Malone’s commentary that Marty Makri could, but will not, remove the shots from the market. The conversation connects these events to broader political and regulatory dynamics, including calls for accountability and for reevaluating emergency approvals in light of emerging data. The piece also touches on fears about future governance of digital identity and related policy implications.

A recent report describes a global review published in Oncotarget on January 3, 2026, by cancer researchers from Tufts University and Brown University, analyzing 69 previously published studies and case reports from around the world. The review identified 333 instances in which cancer was newly diagnosed or rapidly worsened within a few weeks following COVID vaccination, across 27 countries. Circumstances around the publication intensified when Oncotarget’s hosting journal site was hit by a cyberattack, taking the site offline and drawing wider attention to the study. The Daily Mail reported the cyberattack and noted that the journal said disruptions were reported to the FBI, which declined to confirm or deny any investigation into the cyberattack. One of the paper’s authors, Dr. Wafiq Eldiri, faced a smearing campaign, including personal attacks described by him as scientifically illiterate, pathetic whiny wuss, and racial attacks. Eldiri publicly addressed the backlash, stating he was subjected to ongoing public defamation for pursuing scientific truth and listing the insults he received. Days after the paper’s publication, Pfizer reportedly reached out to recruit Eldiri, praising his expertise in oncologic, start-up sciences, and offering senior positions. Eldiri shared the message publicly and declined the offer, noting the ironic timing of a Pfizer recruiter contacting him on January 5, 2026. Eldiri has been vocal about the need for thorough investigations into vaccine safety signals, including potential DNA integration, immune suppression, and cancer risks that could raise questions about emergency approvals. A tweet referenced in the transcript suggested a path to revocation of COVID mRNA vaccine approval by the US FDA for good cause based on emerging evidence of contaminants from altered manufacturing, unexpected biodistribution, and other characteristics in humans, calling for high standards of evidence and significant sanctions if lapses or inaccuracies in reporting are found. The discussion also referenced statements by Doctor Mary Talley Burden about vaccines remaining on the market and exchanges involving Doctor Robert Malone and Marty Makary, with Malone being urged by followers to act, and Makary reportedly able to pull the shots but not doing so. The piece concludes with mentions of ongoing political and regulatory debates, including accusations of interference by the Department of Justice in related cases, and fears about future collaboration between AI, tech, and biotech sectors to accelerate AI-driven vaccine development, describing it as a “nightmare scenario” that must be corrected.

Kellogg's has been called out for selling different, safer ingredients in other countries while using harmful chemicals in the U.S. Over 450,000 signatures have been gathered to demand accountability. During a recent Senate round table, it was highlighted that food companies, like McDonald's, use questionable ingredients in the U.S. that are banned elsewhere. The FDA lacks the capacity to regulate these chemicals effectively, allowing companies to introduce unsafe ingredients without proper oversight. A national boycott of Kellogg's is underway, urging consumers to demand healthier options. Citizens are rallying for change, emphasizing the need for better food safety regulations to protect American health.

Conflicts of interest in regulatory agencies, particularly the FDA, are a major concern for public health. Nearly half of the FDA's budget comes from the pharmaceutical industry, which raises questions about its impartiality. This issue is exemplified by the accelerated approval of an expensive and minimally effective Alzheimer's drug, despite expert disapproval. The revolving door between the FDA and pharmaceutical companies further complicates matters, with many former FDA officials taking lucrative positions in the industry. Similar conflicts exist in the USDA, where a significant majority of dietary guideline panelists have ties to the food industry. It's crucial to eliminate these conflicts to ensure fair and effective health regulations. The food pyramid has historically served economic interests rather than public health, highlighting the need for reform in how dietary guidelines are established.

The speaker claims the Biden administration covered up science related to the COVID shot. Information related to vaccine complications was allegedly censored as COVID vaccine hesitant content. The speaker alleges the heart inflammation in young, healthy men and boys was not disclosed as soon as it should have been, resulting in thousands of kids developing myocarditis unnecessarily. The speaker suggests the administration knew the shot didn't stop transmission but kept it secret. The head of the FDA is cited as saying the Biden administration suppressed information about myocarditis damage to children. The speaker believes this sounds criminal, especially considering mandates for school, work, and travel.

Walz increased taxes on nicotine pouches, claiming concerns about nicotine. However, there's no evidence that nicotine is a carcinogen; this is a misconception. A key point is that nicotine raises testosterone levels, a fact that has been suppressed online. If you search for "nicotine and testosterone," you'll find it difficult to uncover this truth. The decline in testosterone levels among men is significant, and this suppression seems intentional. The fear surrounding testosterone is evident.

Speaker 0 and Speaker 1 discuss the COVID-19 vaccine episode, challenging why the vaccine was pursued as a public health solution and exploring deeper incentives behind the program. - A knowledgeable figure at the stand answered a burning question: did they know the vaccine wouldn’t be effective from the start and could be dangerous? The answer given was that it was “a test of a technology.” The exchange suggests the broader aim was testing an entire program of control previewed in Event 2019. - They ask whether inoculation was necessary on billions, noting it could have been tested on a much smaller population. If shots had been basically empty or inert, the data could have been spun to claim success and end the pandemic, preventing injuries from appearing. The absence of that approach remains a mystery. - The speakers point to high pre-vaccine seroprevalence in 2020, including studies from South Dakota showing 50-60% seroprevalence before vaccine release, implying that a saline shot or no shot could have achieved “indomicity” (immunity) without a vaccine. - They discuss why people might fear vaccines and interpret the broader impact: the public is waking up to something terrible having occurred, as it revealed readiness to lie, potential data quality concerns, and risk to pregnant women and healthy children who might get little justification for risk. - The disease’s lethality is framed as greatest among the very old or very sick; for others, it was less deadly, with natural evolution potentially reducing vulnerability over time. - The mRNA platform was touted as a means to outrun mutations, but the timeline to release was still insufficient to stay ahead of natural change. They note accelerated development was the fastest vaccine in history, from detection to inoculation, reducing the timeline by about a year or two, yet not fast enough. - Political and logistical factors delayed release; there is mention that it would not have appeared under Trump and that Eric Topol argued to delay the rollout. Fauci reportedly sent Moderna back to trials due to insufficient racial diversity in participants. - The discussion questions whether the vaccine qualifies as a normal consumer product, given ongoing subsidies, mandates, indemnifications, wartime-like supports, and propaganda. They wonder if there has been an ongoing two-century revolt by industry against public scrutiny, with public interest repeatedly leading to pushback and rebranding. - A central theme is the sophistication of pharma: the “game of pharma” involves owning an IP-based health claim, crafting supportive research, convincing it is safe and effective, achieving standard-of-care status, securing mandates and government funding, and leveraging ongoing propaganda. They describe pharma as a long-running arms race with deep institutional knowledge, implying that it is far more capable of shaping reality than the public realizes.

In November, the EPA will vote on a bill to add costly water treatment programs to butcher shops, impacting local producers. This move limits consumer choice and favors big packers. The cost is high for small businesses, potentially restricting access to locally sourced meat. The shift may push consumers towards larger corporations controlling most of the industry. Share your thoughts and remember to support American and local businesses.

The government is restricting access to over-the-counter antibiotics and dewormers for farmers, increasing costs. This will require more veterinary care, raising expenses for farmers, ranchers, and homesteaders. The speaker advises stocking up on supplies before the changes take effect. They also mention concerns about potential bans on apps like TikTok being sneaked into other bills.

Hello, I'm Admiral Rachel Levine. This Black History Month, I'm partnering with OMH to promote better health for black communities. Climate change disproportionately affects the physical and mental health of these communities, with many black Americans living in areas that heighten their vulnerability to climate-related health issues. Additionally, 65% report feeling anxious about climate change's impact. Our Office of Climate Change and Health Equity and the Office of Environmental Justice are collaborating with providers and community leaders to find innovative solutions to these health challenges. For more information, visit hhs.gov and join us next Thursday for insights from another HHS leader on supporting black community health.

Admiral Rachel Levine partners with OMH to improve black communities' health during Black History Month. Climate change disproportionately affects black communities' physical and mental health. Black Americans are more vulnerable due to where they live and housing conditions. 65% of black Americans feel anxious about climate change. The Office of Climate Change and Health Equity and the office of environmental justice collaborate with providers and community leaders to find solutions. Visit hhs.gov for more details and hear from HHS leaders next Thursday on contributing to better health for black communities. Learn more at hhs.gov/black-history-month. Produced by the US Department of Health and Human Services.

Admiral Rachel Levine, in partnership with OMH, is focused on advancing better health for black communities during Black History Month. Climate change is disproportionately affecting the physical and mental health of black Americans, who are more likely to live in areas and housing that increase their vulnerability to climate-related health issues. About 65% of black Americans feel anxious about the impact of climate change. The Office of Climate Change and Health Equity and the Office of Environmental Justice are collaborating with providers and community leaders to find innovative approaches that empower communities to address the health consequences associated with climate change. To learn more, visit hhs.gov/blackdashhistorydashmonth. Produced by the US Department of Health and Human Services.

Many Americans, including children, consume harmful substances in their food, contributing to a decline in life expectancy and rising chronic diseases. Our diet, filled with junk foods containing toxic additives like tartrazine, has gone largely unregulated, leading to serious health issues. Tartrazine, originally derived from coal tar, is linked to tumors, asthma, and developmental delays. It’s found not only in junk food but also in seemingly healthy snacks and everyday items. While some harmful additives have been banned in recent years, many remain on the market, affecting children's health. The focus should be on removing these chemicals to improve overall health and well-being. There is hope for change, and efforts are underway to address this public health crisis.

Speaker 0 and Speaker 1 discuss the politicization of science and changes at the NIH. Over the last fifteen to twenty years, the NIH incorporated what Speaker 1 characterizes as political agendas rather than scientific agendas into its portfolio, with DEI (diversity, equity, and inclusion) being the most prominent example. A chunk of NIH funding went to projects focused on achieving social objectives rather than the health mission. Every NIH employee allegedly had to write a loyalty oath to DEI principles and was evaluated on devotion to the cause. Researchers inside and outside the NIH could access funds, with outside researchers more easily securing money if they promised to conduct DEI research, according to Speaker 1. Much of that research allegedly lacked a real scientific basis and was not science. Speaker 1 provides an example of projects they worked to deprioritize: a project asking whether structural racism is the root reason why African Americans have worse hypertension outcomes. The problem, they say, is that there is no way to test the hypothesis because, if structural racism is the cause, there is no workable control group to test the idea as true. They assert that such research did not translate into better health for anybody, including minority populations. They describe these projects as political agendas that do not belong in a science agency. The stated mission is to improve the health of everybody, including minority populations, but only if projects are clearly scientific, well defined, and have a real chance of improving health. Speaker 0 asks for clarification, summarizing that there were ideological or political projects receiving NIH funding. Speaker 1 confirms and adds another practice: when a good science project ended the year with leftover funds, program officers would approach researchers with leftover money and offer a “diversity supplement”—an add-on tied to DEI that was not actual science—to obtain extra funding. This, they claim, was a waste of taxpayer money with no real health benefit. They say they have since gotten rid of all of that.